Efficacy of MabThera in patients with rheumatoid arthritis, by measurement of disease parameters through magnetic resonance of the hand (RESONAR Study).
Phase of Trial: Phase IV
Latest Information Update: 23 May 2014
At a glance
- Drugs Rituximab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms RESONAR
- Sponsors Roche
- 10 Jun 2017 Biomarkers information updated
- 27 Mar 2014 According to ClinicalTrials.gov record, status changed from completed to discontinued.
- 19 Nov 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.